Time Restricted Feeding on Impaired Glucose Regulation(TRIG Trial)

See also
	Status	Clinical Trial	Phase
	Completed	`NCT04283942` - Effect of Intermittent Calorie Restriction on MASLD Patients With Abnormal Glucose Metabolism	N/A
	Completed	`NCT05370560` - Plasma Transthyretin Levels and Risk of Type 2 Diabetes Mellitus and Impaired Glucose Regulation

See also

Status

Clinical Trial

Phase

Completed

NCT04283942 - Effect of Intermittent Calorie Restriction on MASLD Patients With Abnormal Glucose Metabolism

N/A

Completed

NCT05370560 - Plasma Transthyretin Levels and Risk of Type 2 Diabetes Mellitus and Impaired Glucose Regulation

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03802253
Study type	Interventional
Source	The First Affiliated Hospital of Xiamen University
Contact	Changqin Liu, MD&PhD
Phone	+8613376986106
Email	liuchangqin@xmu.edu.cn
Status	Recruiting
Phase	N/A
Start date	June 18, 2019
Completion date	January 31, 2024

Time Restricted Feeding on Impaired Glucose Regulation(TRIG Trial) — TRIG

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms